These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10577095)

  • 1. More about parkinsonism after taking ecstasy.
    Borg GJ
    N Engl J Med; 1999 Oct; 341(18):1400; author reply 1401. PubMed ID: 10577095
    [No Abstract]   [Full Text] [Related]  

  • 2. More about parkinsonism after taking ecstasy.
    Baggott M; Mendelson J; Jones R
    N Engl J Med; 1999 Oct; 341(18):1400-1. PubMed ID: 10577097
    [No Abstract]   [Full Text] [Related]  

  • 3. More about parkinsonism after taking ecstasy.
    Sewell RA; Cozzi NV
    N Engl J Med; 1999 Oct; 341(18):1400; author reply 1401. PubMed ID: 10577096
    [No Abstract]   [Full Text] [Related]  

  • 4. Parkinsonism after taking ecstasy.
    Mintzer S; Hickenbottom S; Gilman S
    N Engl J Med; 1999 May; 340(18):1443. PubMed ID: 10328712
    [No Abstract]   [Full Text] [Related]  

  • 5. What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?
    Kish SJ
    Mov Disord; 2003 Nov; 18(11):1219-23. PubMed ID: 14639660
    [No Abstract]   [Full Text] [Related]  

  • 6. MDMA and Parkinsonism.
    Kuniyoshi SM; Jankovic J
    N Engl J Med; 2003 Jul; 349(1):96-7. PubMed ID: 12840102
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapidly progressive parkinsonism in a self-reported user of ecstasy and other drugs.
    O'Suilleabhain P; Giller C
    Mov Disord; 2003 Nov; 18(11):1378-81. PubMed ID: 14639685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reality of psychomotor problems, and the possibility of Parkinson's disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003).
    Parrott AC; Rodgers J; Buchanan T; Scholey AB; Heffernan T; Ling J
    Psychopharmacology (Berl); 2004 Jan; 171(2):231-3. PubMed ID: 14634710
    [No Abstract]   [Full Text] [Related]  

  • 9. Club drug use in Germany.
    Soellner R
    Subst Use Misuse; 2005; 40(9-10):1279-93. PubMed ID: 16048817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fatal ecstasy intoxication in a 22-year-old man].
    Schilder JN
    Ned Tijdschr Geneeskd; 2007 Oct; 151(41):2295; author reply 2295. PubMed ID: 17987903
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyponatraemic coma after ecstasy ingestion.
    Nuvials X; Masclans JR; Peracaula R; de Latorre FJ
    Intensive Care Med; 1997 Apr; 23(4):480. PubMed ID: 9142593
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ecstasy: a falsely safe drug].
    Avila de Tomás JF
    Med Clin (Barc); 1998 Feb; 110(4):156. PubMed ID: 9541908
    [No Abstract]   [Full Text] [Related]  

  • 14. Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users.
    Parrott AC; Buchanan T; Heffernan TM; Scholey A; Ling J; Rodgers J
    Psychopharmacology (Berl); 2003 Jun; 167(4):449-50. PubMed ID: 12682712
    [No Abstract]   [Full Text] [Related]  

  • 15. Ecstasy use-Parkinson's disease link tenuous.
    Jerome L; Doblin R; Mithoefer M
    Mov Disord; 2004 Nov; 19(11):1386. PubMed ID: 15389978
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability.
    Zimmermann P; Wittchen HU; Waszak F; Nocon A; Höfler M; Lieb R
    Drug Alcohol Depend; 2005 Sep; 79(3):331-41. PubMed ID: 15913921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Medina KL; Shear PK; Corcoran K
    J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hyperpyrexia in an MDMA ("Ecstasy") abuser.
    McCoy EP; Renfrew C; Johnston JR; Lavery G
    Ulster Med J; 1994 Apr; 63(1):103-7. PubMed ID: 8658983
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450.
    Sumnall HR; Jerome L; Doblin R; Mithoefer MC
    Psychopharmacology (Berl); 2004 Jan; 171(2):229-30. PubMed ID: 14634709
    [No Abstract]   [Full Text] [Related]  

  • 20. [Toxicity of ecstasy].
    Mas M; Farré M; Roset PN; Camí J
    Med Clin (Barc); 1998 Oct; 111(13):516-7. PubMed ID: 9859071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.